Literature DB >> 21478109

Glycophenotype of prostatic carcinomas.

M N Khabaz1, J McClure, S McClure, R W Stoddart.   

Abstract

The factors that affect the progression of prostatic carcinoma are poorly understood, but it is known that carbohydrate antigens on the tumour cell surface play a role in the transforming and metastatic processes. The present report aimed to perform a comparative, lectin-histochemical study of benign and carcinomatous prostates, using a battery of lectins, in combination with monoclonal antibodies against Lewis antigens, and a semi quantitative study, to investigate the changes in glycosylation patterns that occur in prostatic carcinoma. Blocks from 27 necropsy cases of prostatic carcinoma were sectioned and stained with H+E, fifteen biotinylated lectins chosen to probe for a wide range of oligosaccharide sequences within several categories of glycoprotein glycans, using a lectin-biotin avidin-peroxidase method, and monoclonal antibodies against Lewisa, sialyl Lewisa and sialyl Lewisx antigens. The glycophenotype of prostatic carcinoma differed from that of the noncancerous prostate in revealing more intense staining with the following lectins (AAA, UEA-1, DBA, WFA, VVA, HPA, BSA-1B4, MPA, ECA, AHA, and CTA), while the binding patterns of (GNA and NPA) were almost similar in both prostatic carcinoma and the noncancerous prostate. Lewis antigens are found to be expressed in prostatic carcinomas but not in the noncancerous prostate. The observations of this study suggest that the gylcophenotype of transformed prostatic cells was modified. It showed a moderate increase in, and changing patterns of, fucosylation and galactosylation, increased branching of side chains and sharp rise in 2 deoxy, 2 acetamido galactosylation and masking process by sialylation, especially by α2-3 and α2-6 linkages. All these changes in the glycosylation pattern of the transformed prostatic cells were observed on O-glycans, no changes were observed on N-glycans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21478109     DOI: 10.2478/v10042-010-0089-9

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  7 in total

1.  Evaluation of glycophenotype in prostatic neoplasm by chemiluminescent assay.

Authors:  Lúcia Patrícia Bezerra Gomes da Silva; Sinara Mônica Vitalino de Almeida; Luiza Rayanna Amorim de Lima; Carmelita de Lima Bezerra Cavalcanti; Mariana Montenegro de Melo Lira; Maria da Paz Carvalho da Silva; Eduardo Isidoro Carneiro Beltrão; Luiz Bezerra de Carvalho Júnior
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Regulation of the metastatic cell phenotype by sialylated glycans.

Authors:  Matthew J Schultz; Amanda F Swindall; Susan L Bellis
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

3.  Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.

Authors:  Hongjun Jin; Mai Xu; Prashanth K Padakanti; Yongjian Liu; Suzanne Lapi; Zhude Tu
Journal:  Mol Pharm       Date:  2013-09-03       Impact factor: 4.939

4.  Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer.

Authors:  Katya Hekimian; Sandra Meisezahl; Kristin Trompelt; Carola Rabenstein; Katharina Pachmann
Journal:  ISRN Oncol       Date:  2012-03-12

5.  Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Authors:  Kazuhisa Hagiwara; Yuki Tobisawa; Takatoshi Kaya; Tomonori Kaneko; Shingo Hatakeyama; Kazuyuki Mori; Yasuhiro Hashimoto; Takuya Koie; Yoshihiko Suda; Chikara Ohyama; Tohru Yoneyama
Journal:  Int J Mol Sci       Date:  2017-01-26       Impact factor: 5.923

6.  Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection.

Authors:  Regina-Veronicka Kalaydina; Hedi Zhou; Elena Markvicheva; Sergey V Burov; Farhana Zulkernine; Myron R Szewczuk
Journal:  Onco Targets Ther       Date:  2019-12-17       Impact factor: 4.147

7.  The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.

Authors:  Jennifer Munkley; Sebastian Oltean; Daniel Vodák; Brian T Wilson; Karen E Livermore; Yan Zhou; Eleanor Star; Vasileios I Floros; Bjarne Johannessen; Bridget Knight; Paul McCullagh; John McGrath; Malcolm Crundwell; Rolf I Skotheim; Craig N Robson; Hing Y Leung; Lorna W Harries; Prabhakar Rajan; Ian G Mills; David J Elliott
Journal:  Oncotarget       Date:  2015-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.